Zdrowie i gospodarka · 17/09/2025
FDA Announces Draft Guidance for Developing Drugs for Disseminated Coccidioidomycosis
The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for disseminated coccidioidomycosis, a serious fungal infection caused by Coccidioides species.